• Explore /
  • Poster
  • / Tumor immune microenvironment (TiME) changes by multiplex IF staining in a pilot study of neoadjuvant talazoparib for early-stage breast cancer patients with a BRCA mutation.

Tumor immune microenvironment (TiME) changes by multiplex IF staining in a pilot study of neoadjuvant talazoparib for early-stage breast cancer patients with a BRCA mutation.

Abstract Poster

Authors

Evthokia Hobbs

Evthokia Hobbs

University of Texas MD Anderson Cancer Center, Houston, TX

Evthokia Hobbs , Fei Yang , Tapsi Kumar , Alejandro Contreras , Edwin Roger Parra Cuentas , Haven Garber , Marion Scoggins , Beatriz E Adrada , Gary J Whitman , Banu Arun , Elizabeth A. Mittendorf , Jennifer Keating Litton

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2019 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Breast Cancer—Local/Regional/Adjuvant

Track

Breast Cancer

Sub Track

Neoadjuvant Therapy

Clinical Trial Registration Number

NCT02282345

Citation

J Clin Oncol 37, 2019 (suppl; abstr 585)

DOI

10.1200/JCO.2019.37.15_suppl.585

Abstract #

585

Poster Bd #

77

Abstract Disclosures

Similar Posters

First Author: Keerthi Gullapalli

First Author: Marie Cumberbatch

First Author: Katherine L. Pogue-Geile

First Author: Jad Chahoud